Literature DB >> 16008694

Histopathological review of sebaceous carcinoma of the eyelid.

Patricia Rusa Pereira1, Alexandre Nakao Odashiro, Abelardo A Rodrigues-Reyes, Zelia Maria S Correa, João Pessoa de Souza Filho, Miguel N Burnier.   

Abstract

BACKGROUND: Sebaceous carcinoma of the eyelid can clinically mimic benign conditions, such as recurrent chalazion and inflammation and histopathologically squamous cell and basal cell carcinoma (BCC). This retrospective study was undertaken as an attempt to improve the characterization and consequently the diagnosis of these tumors.
METHODS: Retrospective analysis was performed on eyelid specimens diagnosed as sebaceous carcinoma retrieved from Henry C. Witelson Ophthalmic Pathology Registry, Canada and Hospital Luis S. Bulnes Pathology Registry, Mexico. Two independent, masked pathologists reviewed the H&E microslides.
RESULTS: Forty-four cases were retrieved, 31 from Canada and 13 from Mexico. Cytoplasmic vacuoles were observed in 48% of the cases. Eighty-four percent of the cases were classified as poorly differentiated lesions. Of these, 75% had features similar to squamous cell carcinoma (SqCC), some with dyskeratosis (30%) and 7% resembled BCC. Solid growth pattern was seen in 26.2% of the cases and lobular growth pattern in 26.2%. Superficial spread resembling Bowen-like disease was observed in 33% of the cases, pagetoid features in 33% and comedocarcinoma in 31.8%.
CONCLUSION: Sebaceous carcinoma presented as a poorly differentiated lesion in most cases of this series, which suggests a possibility of misdiagnosis because of its similarities to SqCC.

Entities:  

Mesh:

Year:  2005        PMID: 16008694     DOI: 10.1111/j.0303-6987.2005.00371.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  9 in total

Review 1.  Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications.

Authors:  Sara C Shalin; Stephen Lyle; Eduardo Calonje; Alexander J F Lazar
Journal:  Histopathology       Date:  2010-01       Impact factor: 5.087

Review 2.  Skin adnexal neoplasms--part 1: an approach to tumours of the pilosebaceous unit.

Authors:  K O Alsaad; N A Obaidat; D Ghazarian
Journal:  J Clin Pathol       Date:  2006-08-01       Impact factor: 3.411

3.  American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival.

Authors:  Bita Esmaeli; Qasiem J Nasser; Hilda Cruz; Melissa Fellman; Carla L Warneke; Doina Ivan
Journal:  Ophthalmology       Date:  2012-02-11       Impact factor: 12.079

Review 4.  Sebaceous Carcinoma: A Review of the Scientific Literature.

Authors:  Thomas Knackstedt; Faramarz H Samie
Journal:  Curr Treat Options Oncol       Date:  2017-08

5.  Multifocal metastasizing extra-ocular facial sebaceous carcinoma as diagnostic challenge: case report and systematic review.

Authors:  Irina Bolm; Gregor Babaryka; Maximilian Moergel; Bilal Al-Nawas; Peer W Kämmerer
Journal:  J Maxillofac Oral Surg       Date:  2013-06-20

6.  Surgical treatment of a solitary pulmonary metastasis from eyelid sebaceous carcinoma: report of a case.

Authors:  Kaoru Kaseda; Takashi Ohtsuka; Yuichiro Hayashi; Katsura Emoto; Keisuke Asakura; Ikuo Kamiyama; Taichiro Goto; Mitsutomo Kohno
Journal:  World J Surg Oncol       Date:  2014-04-23       Impact factor: 2.754

7.  Sebaceous Carcinoma: Clinicopathologic Analysis of 29 Cases in a Tertiary Hospital in Korea.

Authors:  Su Kyung Park; Jin Park; Han Uk Kim; Seok Kweon Yun
Journal:  J Korean Med Sci       Date:  2017-08       Impact factor: 2.153

8.  Left Buttock Sebaceus Carcinoma: A Case Report and Review of the Literature.

Authors:  Răzvan Mercuţ; Mihaela Ionescu; Cristiana Simionescu; Vlad Pîrvănescu; Maria Filoftea Mercuţ; Alexandru Gogănău; Marius Eugen Ciurea
Journal:  Curr Health Sci J       Date:  2021-12-31

9.  The effect of direct cell injury inflicted by cryotherapy on eyelid sebaceous gland carcinoma cells: An ex-vivo experimental study.

Authors:  Md Shahid Alam; Prabrisha Banerjee; Subramanian Krishnakumar
Journal:  Indian J Ophthalmol       Date:  2022-02       Impact factor: 2.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.